Evidence map›Paper›PMID 33602283›Full record

ArticleReproductive biology and endocrinology : RB&E2021

Commentary on two recently published formal guidelines on management of "mosaic" embryos after preimplantation genetic testing for aneuploidy (PGT-A).

Norbert Gleicher, David H Barad, Zion Ben-Rafael, Demian Glujovsky, Lyka Mochizuki, Deepak Modi, Maximillian Murtinger, Pasquale Patrizio, Raoul Orvieto, Shizuko Takahashi and 3 more

Abstract readEditorialComment
In one paragraph

Article in Reproductive biology and endocrinology : RB&E, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. PGT-A: what's it for, what's wrong?Journal of assisted reproduction and genetics · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Preimplantation genetic testing for aneuploidy: The management of mosaic embryos.Clinical and experimental reproductive medicine · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Norbert GleicherThe Center for Human Reproduction, 21 East 69th Street, New York, NY, 10021, USA. ngleicher@thechr.com.
David H BaradThe Center for Human Reproduction, 21 East 69th Street, New York, NY, 10021, USA.
Zion Ben-RafaelDepartment of Obstetrics and Gynecology and IVF, Laniado Medical Center, Netanya, Israel.
Demian GlujovskyFertility Argentina, Buenos Aires, Argentina.
Lyka MochizukiThe Center for Human Reproduction, 21 East 69th Street, New York, NY, 10021, USA.
Deepak ModiMolecular and Cellular Biology Laboratory, ICRM-National Institute for Research in Reproductive Health, Mumbai, India.
Maximillian MurtingerNextXlinic IVF Centers Prof Zech, Bregenz, Austria.
Pasquale PatrizioYale Fertility Center, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, Yale University, New Haven, CT, USA.
Raoul OrvietoInfertility and IVF Unit, Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Shizuko TakahashiDepartment of Biomedical Ethics and the Department of Obstetrics and Gynecology, The University of Tokyo, Graduate School of Medicine, Tokyo, Japan.
Andrea WeghoferThe Center for Human Reproduction, 21 East 69th Street, New York, NY, 10021, USA.
Søren ZiebeThe Fertility Clinic, Ringhospital, University Hospital of Copenhagen, Copenhagen, Denmark.
International Do No Harm Group in IVF (IDNHG-IVF)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two professional societies recently published opinions on the clinical management of "mosaic" results from preimplantation genetic testing for aneuploidy (PGT-A) in human blastocyst-stage embryos in associations with in vitro fertilization (IVF). We here point out three principal shortcomings: (i) Though a most recent societal opinion states that it should not be understood as an endorsement of the use of PGT-A, any discussion of how PGT-A should be clinically interpreted for all practical purposes does offer such an endorsement. (ii) The same guideline derived much of its opinion from a preceding guidance in favor of utilization of PGT-A that did not follow even minimal professional requirements for establishment of practice guidelines. (iii) Published guidelines on so-called "mosaic" embryos from both societies contradict basic biological characteristics of human preimplantation-stage embryos. They, furthermore, are clinically unvalidated and interpret results of a test, increasingly seen as harmful to IVF outcomes for many infertile women. Qualified professional organizations, therefore, should finally offer transparent guidelines about the utilization of PGT-A in association with IVF in general.

Indexed as

Infertility, FemalePreimplantation DiagnosisAneuploidyFemaleFertilization in VitroGenetic TestingHumansPregnancyGuidelinesIn vitro fertilization (IVF)MosaicismPreimplantation genetic testing for aneuploidy (PGT-A)Professional organizations

Identifiers

PMID33602283
PMCPMC7890905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.